General
Preferred name
IOMEPROL
Synonyms
Iomervu ()
E7337 ()
Iomeron 300 ()
E-7337 ()
P&D ID
PD013747
CAS
78649-41-9
Tags
available
drug
Drug Status
approved
investigational
Max Phase
4.0
Drug indication
diagnostic agent
First approval
2024
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
10
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
NPC Screening Collection
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
29
Properties
(calculated by RDKit )
Molecular Weight
776.85
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
7
Rotatable Bonds
10
Ring Count
1
Aromatic Ring Count
1
cLogP
-1.38
TPSA
179.66
Fraction CSP3
0.47
Chiral centers
2.0
Largest ring
6.0
QED
0.14
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
